High Expression of CLEC11A Predicts Favorable Prognosis in Acute Myeloid Leukemia

BACKGROUND: Acute myeloid leukemia (AML) is a heterogeneous disease of the hematopoietic system, for which identification of novel molecular markers is potentially important for clinical prognosis and is an urgent need for treatment optimization. METHODS: We selected C-type lectin domain family 11,...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Chengliang, Zhang, Junyan, Guan, Wei, Dou, Liping, Liu, Yuchen, Shen, Ming, Jia, Xiaodong, Xu, Lu, Wu, Rilige, Li, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7966831/
https://www.ncbi.nlm.nih.gov/pubmed/33747924
http://dx.doi.org/10.3389/fonc.2021.608932

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7966831/
https://www.ncbi.nlm.nih.gov/pubmed/33747924
http://dx.doi.org/10.3389/fonc.2021.608932

Ejemplares similares